Searchable abstracts of presentations at key conferences in endocrinology

ea0063s22.3 | The pituitary as metabolic sensor (Endorsed by Endocrine Connections) | ECE2019

Bidirectional interrelationship between growth hormone and metabolism

Luque Raul M

Growth hormone (GH)-producing pituitary cells (somatotropes) comprise a fundamental regulator for a plethora of relevant physiological functions, including somatic growth and whole-body metabolism, by controlling the function of different endocrine/non-endocrine targets. Synthesis and release of GH has been classically thought to be primarily regulated by central, dual neuroendocrine signals: i.e. GH-releasing hormone and somatostatin. However, it is progressively becoming evi...

ea0040l17 | Truncated sst5 receptor variants in pituitary tumors and cancer | ESEBEC2016

Truncated sst5 receptor variants in pituitary tumors and cancer

Luque Raul M , Ibanez-Costa Alejandro , Gahete Manuel D , Castano Justo P

Endocrine-related cancers comprise a complex group of heterogeneous pathologies whose development and progression are profoundly conditioned by endocrine–metabolic deregulations. The well-known capacity of somatostatin (SST) to inhibit hormone secretion and cell proliferation in a wide variety of cell types, coupled to the ubiquitous expression of SST receptors (ssts) in normal and tumoral tissues, has led SST analogs (SSAs) to be extensively used in clinical practice for...

ea0040p24 | (1) | ESEBEC2016

Functional role of somatostatin receptor subtype 1 (sst1) in prostate cancer: an in vitro approach

Pedraza-Arevalo Sergio , Hormaechea-Agulla Daniel , Selth Luke A , Castano Justo P , Luque Raul M

Prostate cancer (PC), the most commonly diagnosed malignancy among men, is a complex and heterogeneous disease that is highly influenced by the endocrine environment, which makes difficult the identification of novel therapeutic biomarkers to treat this pathology. Somatostatin (SST) is a pleiotropic neuropeptide that exerts its multiple biological functions, including tumor cell regulation, through a family of receptors (named sst1-5). Particularly, in this study we have found...

ea0040p25 | (1) | ESEBEC2016

Metformin suppressed the proliferation of prostate cancer cells in vitro and reduced prostate tumor growth in vivo under low-fat and, especially, under high-fat fed conditions

Sarmento-Cabral Andre , Lopez-Lopez Fernando , Castano Justo P , Luque Raul M

Obesity (Ob) is a chronic endocrine-metabolic disease and one of the most serious and complex threats for the human health, which is associated with an increased incidence of some types of cancers such as prostate cancer (PC), the second most common cancer in men worldwide. Interestingly, metformin (Met), an antidiabetic drug, might represents a very promising opportunity to treat Ob and PC as some retrospective clinical studies have shown that the incidence of PC is lower in ...

ea0032s11.1 | New mechanisms in SST analogue response | ECE2013

Functional relevance of truncated SST5 receptor variants

Luque Raul M , Ibanez-Costa Alejandro , Gahete Manuel D , Castano Justo P

Somatostatin (SST) and its related peptide cortistatin (CORT) exert multiple physiological actions through binding to a family of G-protein coupled receptors (sst1–sst5), commonly bearing seven transmembrane domains (TMDs). However, we have recently discovered that human, pig and rodent sst5 gene also generate, through non-canonical alternative splicing, novel truncated albeit functional sst5 variants that lack one o more TMDs. Our studies indicate that truncated sst5 var...

ea0032s30.3 | Energy Status and pituitary function | ECE2013

Energy status and GH/IGF1 axis

Gahete Manuel , Cordoba-Chacon Jose , Christian Helen , Luque Raul , Kineman Rhonda

GH levels decline with age and weight gain and are enhanced in response to nutrient deprivation. Under these circumstances, GH levels are negatively correlated with IGF1 and insulin levels. Since IGF1 and insulin can directly inhibit GH synthesis and release from primary pituitary cells of different species, it is commonly accepted that changes in circulating IGF1 and insulin serve to directly regulate somatotrope function in response to metabolic extremes. However, teasing ap...

ea0020oc4.3 | Acromegaly/IGF1/Type 2 Diabetes | ECE2009

Homologous and heterologous in vitro regulation of pituitary receptors for somatostatin (SST), growth hormone (GH)-releasing hormone (GHRH) and ghrelin in a non-human primate (Papio anubis)

Chacon Jose Cordoba , Castano Justo P , Kineman Rhonda D , Luque Raul M

Secretion of GH by pituitary somatotropes is primarily stimulated by GHRH and ghrelin and inhibited by SST through the activation of specific receptors (GHRH-R, GHS-R and Sstr1-5, respectively). However, we have previously shown that SST, at low doses, can also stimulate GH release, directly and specifically, in primary pituitary cell cultures from baboons (Papio anubis) and pigs. To determine whether these primary regulators of GH release can also regulate directly the...

ea0049ep882 | Growth hormone IGF axis - basic | ECE2017

Could statin modify molecular phenotype of pituitary growth hormone-secreting tumors?

Exposito Maria Rosa Alhambra , Moreno Paloma Moreno , Jimenez Concepcion Munoz , Moreno Maria Angeles Galvez , Huertas Raul Luque

Background: Acromegaly is the consequence of excessive growth hormone (GH) secretion, usually produced by a pituitary adenoma. In the last years, statins have been implicated in the response to treatment of patients with acromegaly. Although this fact is not very clear.Objective: To analyze whether pretreatment with statins modifies the adenoma molecular phenotype of the acromegalic patients and how this changes could help to influence the response to tr...

ea0022p655 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Kisspeptin selectively increases LH and GH, but not FSH, ACTH, PRL or TSH, release in primary pituitary cell cultures from a non-human primate (Papio anubis) via distinct signaling pathways and under influence of sex steroids

Cordoba-Chacon Jose , Luque Raul M , Gahete Manuel D , Kineman Rhonda D , Tena-Sempere Manuel , Castano Justo P

Kisspeptins (Kp), a peptide family encoded by Kiss1 gene, and their receptor Kiss1r were first identified by their anti-metastatic actions but have emerged as key regulators of the reproductive axis, where they integrate sexual, metabolic and seasonal cues to control hypothalamic GnRH release. Recent data indicates that some actions of Kps may be effected directly at the pituitary (PIT), since Kissr1 is expressed in the PIT and Kp stimulate luteinizing hormone (LH) secretion d...

ea0081oc10.5 | Oral Communications 10: Diabetes, Obesity, Metabolism and Nutrition 3 | ECE2022

Splicing dysregulation is associated with aggresive and metabolic-associated liver disease-derived hepatocellular carcinoma

Sanchez Natalia Herman , Lopez-Canovas Juan L , del Rio-Morenos Mercedes , Amado Victor , de la Mata Manuel , Rodriguez-Peralvarez Manuel , Luque Raul M , Gahete Manuel D

Metabolic-associated fatty liver disease (MAFLD) is a growing cause of hepatocellular carcinoma (HCC), but the molecular mechanisms associated with the pathological progression from MAFLD to HCC are still to be fully elucidated. The genomic and transcriptomic profile of HCC samples have been widely described; however, the proteomic landscape of MAFLD-derived HCC samples is mostly unknown. Here, we sought to perform the first quantitative proteomic analysis of HCC samples from ...